Comparing Efficacy and Safety: Vortioxetine vs. Sertraline in Anxiety Disorder Treatment
- Conditions
- Health Condition 1: F411- Generalized anxiety disorder
- Registration Number
- CTRI/2024/04/066458
- Lead Sponsor
- Mitsha Nagpal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Both male and female patients aged between 18 and 60 years.
2. Those giving written consent/guardians giving written consent (in cases where the patients were too ill to understand the process of informed consent and give an informed choice.)
3. People diagnosed with anxiety disorder as per ICD-10 diagnostic criteria.
4. HAM-A score =18
1. Systemic or Neurological Disorder affecting Cognition, Behavior or Mental Status.
2. Substance dependence except for Nicotine and Caffeine within the past month of entering the study.
3. Long-standing medical or surgical illnesses.
4. Patients with mental retardation or organic brain disorders.
5. Patients suffering from neurological, metabolic and vascular conditions affecting sexual function.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method